loader image
Wednesday, December 24, 2025
69.8 F
McAllen
- Advertisement -

A Simple Colonoscopy Can Save Your Life

Translate to Spanish or other 102 languages!

A routine screening for colorectal cancer beginning at age 45 can save lives! Image for illustration purposes
A routine screening for colorectal cancer beginning at age 45 can save lives! Image for illustration purposes

Mega Doctor News

- Advertisement -

By Texas Tech University Health Sciences Center El Paso

Newswise — A routine screening for colorectal cancer beginning at age 45 can save lives! In cancers that affect both men and women, colorectal cancer is the second leading cancer killer—but most cases can be prevented with routine screening tests.

Colorectal cancer usually starts from precancerous polyps in the colon or rectum. Over time, some polyps can turn into cancer.

- Advertisement -

Screening tests aid in finding precancerous polyps, so they can be removed before they turn into cancer. Screening tests can also find colorectal cancer early, when treatment works best.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Does Age Affect Recovery From Spinal Cord Injury?

A new study published on December 23, 2025, in Neurology®, the medical journal of the American Academy of Neurology, looks at how age may affect recovery for people with spinal cord injuries.

AMA Offers 10 Health Recommendations for the New Year

As the new year quickly approaches, the American Medical Association (AMA) is offering 10 recommendations to help Americans make the most impactful, long-lasting improvements to their health in 2026 and beyond.

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.
- Advertisement -
×